Universal T cell targeted influenza vaccine

Ended Project Grant Awarded Last action

Award ID
R01AI130190
Recipient
Awarding agency
Obligated
$5,262,961

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Funding
  • $4,509,755.46 Federal
  • $753,206.00 Non-federal
Place of performance
Missouri, USA

Award details come from USAspending.gov.

Transactions

Action Federal Non-federal Date
Amendment -$6,966 $0
Amendment $731,376 $0
Amendment $741,275 $0
Amendment $741,275 $0
Amendment $753,206 $0
Amendment $753,206 $753,206
Original award $796,383 $0

Subawards

Subrecipient Amount Awarded
Medigen, Inc. • Design strategies to generate recombinant protein and VLP-encapsidated RNA vaccines. Produce vaccines for testing in vitro and in animal models at SLU $6,200

Quick answers

Who received award R01AI130190?

R01AI130190 was awarded to Saint Louis University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2020.

How much is award R01AI130190 worth?

$5,262,961 has been obligated on R01AI130190: $4,509,755 in federal funding and $753,206 in non-federal funding.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award